Chandra Bhagat Pharma (BOM:542934) 3-Year EBITDA Growth Rate : -9.00% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Chandra Bhagat Pharma 3-Year EBITDA Growth Rate?

Chandra Bhagat Pharma's EBITDA per Share for the six months ended in Sep. 2023 was ₹2.66.

During the past 12 months, Chandra Bhagat Pharma's average EBITDA Per Share Growth Rate was 2.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -9.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Chandra Bhagat Pharma was 1.40% per year. The lowest was -9.00% per year. And the median was -4.30% per year.

Competitive Comparison of Chandra Bhagat Pharma's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Chandra Bhagat Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chandra Bhagat Pharma's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chandra Bhagat Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Chandra Bhagat Pharma's 3-Year EBITDA Growth Rate falls into.

Chandra Bhagat Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Chandra Bhagat Pharma (BOM:542934) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Chandra Bhagat Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Chandra Bhagat Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Chandra Bhagat Pharma (BOM:542934) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chandra Bhagat Pharma Ltd (BOM:542934) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Doctor Ambedkar Road, 323-F Bhagat Bhuvan, Matunga (East), Mumbai, MH, IND, 400019

Website

https://www.cbcpharma.com

Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.

Chandra Bhagat Pharma (BOM:542934) Headlines

No Headlines